From the Blood Journals

From the Blood Journals

Research from the Blood family of journals: Blood and Blood Advances

Does Rheumatic Disease Increase Risk of MGUS Progression to Hematologic Malignancies?

Patients with monoclonal gammopathy of undetermined significance (MGUS) and concomitant non-antibody (Ab)–mediated inflammatory rheumatic diseases are at increased risk of progression to overt multiple...

More COVID-19 Complications Seen in Black Patients With Sickle Cell Disease and Sickle Cell...

Patients with sickle cell disease (SCD) and sickle cell trait (SCT) have significantly higher rates of hospitalization, pneumonia, and pain related to COVID-19 compared...
WIB_icon

Evaluating Ibrutinib in Patients With Heavily Pretreated Hairy Cell Leukemia

Treatment with ibrutinib offered durable disease control in patients with heavily pretreated classic and variant relapsed hairy cell leukemia (HCL) who were not expected...
WIB_icon

Older Patients With Myeloma May Have Suboptimal Response to COVID-19 Vaccination

According to a study published in Blood, older patients with multiple myeloma (MM) experienced reduced efficacy with BNT162b2, Pfizer/BioNTech’s COVID-19 vaccine. However, certain factors...
WIB_icon

International Prognostic Tool Predicts Outcomes in Angioimmunoblastic T-Cell Lymphoma

Researchers have created a novel prognostic score to predict outcomes in patients with angioimmunoblastic T-cell lymphoma (AITL), stratifying them into low-, intermediate-, and high-risk...

Tandem High-Dose Influenza Vaccine Offers Durable Seroprotection for Patients With Plasma Cell Dyscrasias

Tandem high-dose influenza vaccination may result in more durable serologic immunity in patients with plasma cell dyscrasias (PCDs), compared with standard vaccination, according to...
WIB_icon

Acalabrutinib Induces Durable Remission in Patients With Treatment Naïve Chronic Lymphocytic Leukemia

Treatment with the next-generation covalent Bruton tyrosine kinase (BTK) inhibitor acalabrutinib was safe and led to durable, long-term remission in a small group of...

Can Caloric Restriction Improve Chemotherapy Response in Overweight Patients With ALL?

Previous reports have found that patients who are overweight or obese during B-cell acute lymphocytic leukemia (B-ALL) induction therapy are at a higher risk...
WIB_icon

Reduced Calf Muscle Pump Function Predicts VTE and Mortality Risk

Reduced calf pump function (CPF) appears to be a risk factor for venous thromboembolism (VTE), according to a study published in Blood. In addition,...
WIB_icon

Adding Brentuximab Vedotin to Chemotherapy Improves Outcomes in Pediatric ALK-Positive ALCL

The addition of brentuximab vedotin to chemotherapy led to favorable overall survival (OS) and event-free survival (EFS) in children with ALK-positive anaplastic large cell...
Advertisement

Current Issue

June 2021 Volume 7 Issue 7

This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

Block title